Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection

Pityriasis rosea infection in a COVID-19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prodromal symptom of an underlying SARS-CoV-2 infection / Paolino, G.; Di Nicola, M. R.; Cantisani, C.; Mercuri, S. R.. - In: DERMATOLOGIC THERAPY. - ISSN 1396-0296. - 34:4(2021). [10.1111/dth.14972]